edatrexate has been researched along with Lung Neoplasms in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (4.17) | 18.7374 |
1990's | 19 (79.17) | 18.2507 |
2000's | 4 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gralla, RJ | 1 |
Cheson, B; Christian, M; Feigal, EG; Friedman, MA; Grever, M | 1 |
Grant, SC; Kris, MG | 1 |
Klastersky, J | 1 |
Grant, SC; Kris, MG; Miller, VA; Pisters, KM; Rigas, JR | 1 |
Chou, TC; Fletcher, TS; Hack, FM; Perez, EA | 1 |
Chou, TC; Hack, FM; Perez, EA; Webber, LM | 1 |
Braich, TA; Jett, JR; Kardinal, CG; Mailliard, JA; Michalak, JC; Morton, RF; Su, JQ; Veeder, MH; Wiesenfeld, M | 1 |
Allen, R; Harland, SJ; Hartley, JM; Lamond, P; Nicholson, PW; Souhami, RL | 1 |
Otter, GM; Schmid, FA; Sirotnak, FM | 1 |
Edelman, MJ; Gandara, DR | 1 |
Anderson, M; Chu, E; Dearing, MP; Englee-Miller, MJ; Gazdar, AF; Kramer, BS; Kratzke, RA; Mulshine, JL; Venzon, D; Weinstein, J | 1 |
Crowley, JJ; Edelman, MJ; Gandara, DR; Lau, DH; Livingston, RB | 1 |
Colwell, WT; DeGraw, JI; Piper, JR; Sirotnak, FM | 1 |
Kris, MG; Miller, VA; Scher, HI; Sirotnak, FM; Zakowski, MF | 1 |
Chronowski, G; Heelan, RT; Kris, MG; Laurie, SA; Pfister, DG; Pisters, KM; Sirotnak, FM; Tong, WP | 1 |
Colon-Otero, G; Geyer, S; Hillman, SH; Jett, JJ; Krook, JE; Marks, RS; Niedringhaus, RD; Sloan, J; Tschetter, LK; Wiesenfeld, M; Windschitl, HE | 1 |
Gandara, DR; Kuriakose, P; Perez, EA | 1 |
Allen, R; Harper, PG; Lamond, P; Rudd, RM; Souhami, RL; Spiro, SG | 1 |
Yoshimura, A | 1 |
Hong, WK; Lee, JS; Murphy, WK; Pang, A; Shirinian, MH | 1 |
Dimery, IW; Fossella, FV; Glisson, BS; Hong, WK; Lee, JS; Libshitz, HI; Lippman, SM; Murphy, WK; Pang, AC; Shin, DM | 1 |
Hong, WK; Jeffries, D; Lee, JS; Libshitz, HI; Murphy, WK | 1 |
Burke, MT; Gralla, RJ; Heelan, RT; Kris, MG; Marks, LD; Shum, KY | 1 |
7 review(s) available for edatrexate and Lung Neoplasms
Article | Year |
---|---|
Edatrexate studies in non-small cell lung cancer.
Topics: Aminopterin; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Folic Acid Antagonists; Humans; Lung Neoplasms | 1995 |
New chemotherapeutic agents in non-small-cell lung cancer.
Topics: Aminopterin; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Drug Design; Humans; Interferons; Irinotecan; Lung Neoplasms; Paclitaxel; Topotecan; Vinblastine; Vinorelbine | 1993 |
New antineoplastic agents in lung cancer 1988-1993.
Topics: Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Humans; Irinotecan; Lung Neoplasms; Nitrosourea Compounds; Organophosphorus Compounds; Paclitaxel; Teniposide; Vinblastine; Vinorelbine | 1995 |
New drug for therapy of non-small cell lung cancer.
Topics: Aminopterin; Antineoplastic Agents; Camptothecin; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Paclitaxel; Taxoids; Vinblastine; Vinorelbine | 1994 |
New chemotherapeutic agents for non-small cell lung cancer.
Topics: Aminopterin; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Paclitaxel; Quinoxalines; Sulfanilamides; Taxoids; Topotecan; Vinblastine; Vinorelbine | 1995 |
Promising new agents in the treatment of non-small cell lung cancer.
Topics: Aminopterin; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Lung Neoplasms; Paclitaxel; Taxoids; Vinblastine; Vinorelbine | 1996 |
[New analogues of methotrexate].
Topics: Aminopterin; Animals; Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Methotrexate; Trimetrexate | 1992 |
7 trial(s) available for edatrexate and Lung Neoplasms
Article | Year |
---|---|
Phase II trial of edatrexate in small cell lung cancer.
Topics: Aged; Aminopterin; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Analysis | 1994 |
Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group study.
Topics: Adult; Aged; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mouth Mucosa; Neutropenia; Survival Analysis; Treatment Outcome | 1997 |
Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin.
Topics: Adult; Aged; Aminopterin; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Female; Folic Acid Antagonists; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Time Factors; Treatment Outcome | 2001 |
A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: a North Central Cancer Treatment Group Trial.
Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Recombinant Proteins; Remission Induction; Sickness Impact Profile; Survival Analysis; Vinblastine | 2001 |
Phase I trial of edatrexate in advanced breast and other cancers.
Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Infusions, Intravenous; Karnofsky Performance Status; Lung Neoplasms; Maximum Tolerated Dose; Melanoma; Menopause; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Treatment Outcome | 2002 |
Phase II study of Edatrexate in stage III and IV non-small-cell lung cancer.
Topics: Aged; Aminopterin; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Neoplasm Staging | 1992 |
Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer.
Topics: Adult; Aged; Aminopterin; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Evaluation; Drug Synergism; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1991 |
10 other study(ies) available for edatrexate and Lung Neoplasms
Article | Year |
---|---|
Modulation of intrinsic in vitro resistance to carboplatin by edatrexate in the A549 human nonsmall cell lung cancer cell line.
Topics: Aminopterin; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance; Humans; Kinetics; Lung Neoplasms; Time Factors; Tumor Cells, Cultured | 1994 |
Schedule-dependent synergism of edatrexate and cisplatin in combination in the A549 lung-cancer cell line as assessed by median-effect analysis.
Topics: Adenocarcinoma; Aminopterin; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Humans; Lung Neoplasms; Tumor Cells, Cultured | 1993 |
Pharmacokinetics of 10-ethyl-10-deaza-aminopterin, edatrexate, given weekly for non-small-cell lung cancer.
Topics: Aminopterin; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chromatography, High Pressure Liquid; Creatinine; Half-Life; Humans; Lung Neoplasms; Metabolic Clearance Rate | 1993 |
Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
Topics: Adenocarcinoma; Aminopterin; Animals; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fibrosarcoma; Leucovorin; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma, Experimental; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Salvage Therapy | 1993 |
Dipyridamole mediated enhanced antiproliferative activity of 10-ethyl-10-deazaaminopterin (10-EDAM) against human lung cancer cell lines.
Topics: Aminopterin; Biological Transport; Cell Division; Depression, Chemical; Dipyridamole; Dose-Response Relationship, Drug; Drug Synergism; Folic Acid Antagonists; Growth Inhibitors; Humans; Lung Neoplasms; Methotrexate; Nucleosides; Thymidine; Tumor Cells, Cultured | 1996 |
A new analogue of 10-deazaaminopterin with markedly enhanced curative effects against human tumor xenografts in mice.
Topics: Aminopterin; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Enzyme Inhibitors; Folic Acid Antagonists; Humans; Lung Neoplasms; Methotrexate; Mice; Mice, Nude; Structure-Activity Relationship; Substrate Specificity; Tetrahydrofolate Dehydrogenase; Tumor Cells, Cultured | 1998 |
Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase.
Topics: Aminopterin; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carboplatin; Cell Division; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; ErbB Receptors; Female; Gefitinib; Humans; Immunohistochemistry; Lung Neoplasms; Male; Maximum Tolerated Dose; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Prostatic Neoplasms; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; Taxoids; Time Factors; Tumor Cells, Cultured; Vinblastine; Vinorelbine; Vulvar Neoplasms | 2000 |
Alleviation by leucovorin of the dose-limiting toxicity of edatrexate: potential for improved therapeutic efficacy.
Topics: Aminopterin; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Evaluation; Drug Tolerance; Female; Folic Acid Antagonists; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged; Stomatitis | 1991 |
Phase II study of 10-ethyl-10-deaza-aminopterin (10-EdAM; CGP 30 694) for stage IIIB or IV non-small cell lung cancer.
Topics: Adult; Aged; Aminopterin; Carcinoma, Non-Small-Cell Lung; Female; Folic Acid Antagonists; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pleural Effusion | 1990 |
Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small-cell lung cancer.
Topics: Aged; Aminopterin; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Folic Acid Antagonists; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging | 1988 |